Why we invested in ImmuONE

Before a new drug, chemical or product is launched, assessing safety for humans is crucial. Historically, this often meant testing on animals. Not only does this pose ethical concerns, but evidence suggests that up to 90% of drugs deemed safe and effective in animals turn out not to work as planned in humans. With animal testing’s questionable accuracy, the hunt was on for more ethical and effective alternatives. For the past 15 years, scientists around the world have been developing lab-based 3D models that are on par with, or even surpass, animal research in mimicking human physiology and architecture. Regulations are changing too. The UK banned the testing of cosmetics products on animals in 1998 and the US passed landmark federal legislation in 2022 eliminating mandatory animal testing for new drugs ahead of human trials. It’s an exciting time in the in-vitro toxicology testing market. <a href="https://medium.com/@hannahtapsell/why-we-invested-in-immuone-3d998fb8e175">Read More</a>